Justin I Odegaard Selected Research

Obesity

6/2014	Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.
6/2008	Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.
6/2007	Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Justin I Odegaard Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
5	Inflammation (Inflammations) 01/2019 - 07/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2018
3	Schistosomiasis haematobia (Schistosomiasis haematobium) 01/2020 - 01/2015
3	Hemorrhage 01/2019 - 01/2015
3	Hemorrhagic Cystitis 01/2019 - 01/2018
3	Fibrosis (Cirrhosis) 01/2015 - 01/2012
3	Obesity 06/2014 - 06/2007
2	Microsatellite Instability 12/2019 - 01/2018
2	Pain (Aches) 01/2019 - 01/2018
2	Infections 04/2016 - 12/2010
2	Insulin Resistance 06/2008 - 06/2007
1	Neoplasm Metastasis (Metastasis) 08/2021
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Urinary Tract Infections (Urinary Tract Infection) 12/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020
1	Disease Progression 01/2020
1	Hyperplasia 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cystitis 01/2019
1	Schistosomiasis (Bilharziasis) 01/2019
1	Coinfection 03/2018
1	Virus Diseases (Viral Diseases) 03/2018
1	Urinary Bladder Diseases (Bladder Diseases) 01/2018
1	Granuloma 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2014
1	Leukemia 07/2014
1	Ameloblastoma 07/2014
1	Odontogenic Tumors (Dental Tissue Neoplasm) 07/2014
1	Tendinopathy (Tendonitis) 06/2012
1	Carcinogenesis 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2009
1	Kidney Diseases (Kidney Disease) 11/2009
1	Glucose Intolerance 06/2007

Drug/Important Bio-Agent (IBA)

11	Circulating Tumor DNAIBA 01/2022 - 01/2018
7	Cell-Free Nucleic AcidsIBA 01/2022 - 12/2017
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2014
5	Interleukin-4 (Interleukin 4)IBA 01/2019 - 12/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2017
2	Mesna (Coenzyme M)FDA LinkGeneric 01/2019 - 01/2018
2	Ifosfamide FDA LinkGeneric 01/2019 - 01/2018
2	ChemokinesIBA 01/2015 - 06/2007
1	pertuzumabIBA 11/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	human ERBB2 proteinIBA 11/2021
1	Peptides (Polypeptides)IBA 12/2020
1	Hormones (Hormone)IBA 01/2020
1	AlpelisibIBA 01/2020
1	CarcinogensIBA 01/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	osimertinibIBA 01/2019
1	Acrolein (Aqualin)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	B7-H1 AntigenIBA 01/2018
1	pembrolizumabIBA 01/2018
1	ResistinIBA 04/2016
1	SolutionsIBA 01/2016
1	Liposomes (Liposome)IBA 01/2015
1	Clodronic Acid (Clodronate)IBA 01/2015
1	Heterophile AntigensIBA 01/2015
1	CalciumIBA 10/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	VemurafenibIBA 07/2014
1	Mitogen-Activated Protein KinasesIBA 07/2014
1	Arsenic Trioxide (Trisenox)FDA Link 07/2014
1	Hematoxylin (Haematoxylon)IBA 06/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	CollagenIBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	Insulin (Novolin)FDA Link 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 12/2010
1	AutoantibodiesIBA 11/2009
1	PPAR deltaIBA 06/2008
1	CCR2 ReceptorsIBA 06/2007
1	PPAR gammaIBA 06/2007
1	LigandsIBA 06/2007
1	CytokinesIBA 07/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2006
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2018
1	Hepatectomy 08/2021
1	Immunotherapy 12/2019
1	Cell Transplantation 03/2018
1	Injections 06/2012